Compounds > arginine

arginine and bortezomib

arginine has been researched along with bortezomib in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Anderson, KC; Antón, IM; Calamito, M; de la Fuente, MA; Elkhal, A; Gallego, MD; Geha, RS; Ochs, HD; Ramesh, N; Rosen, FS; Sasahara, Y; Siminovitch, K; Suresh, K1
Kazmi, MA; Peeler, JC; Sakmar, TP; Schedin-Weiss, S; Soula, M1
Hobeika, L; Self, SE; Velez, JC1
Alici, E; Borg Bruchfeld, J; Gahrton, G; Gran, C; Lund, J; Månsson, R; Nahi, H; Uttervall, K; Wålinder, G1

Reviews

1 review(s) available for arginine and bortezomib

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for arginine and bortezomib

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
WIP is a chaperone for Wiskott-Aldrich syndrome protein (WASP).
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Jan-16, Volume: 104, Issue:3

    Topics: Actins; Animals; Arginine; Boronic Acids; Bortezomib; Calpain; Carrier Proteins; Cytoskeletal Proteins; Enzyme Inhibitors; Humans; Interleukin-2; Intracellular Signaling Peptides and Proteins; Jurkat Cells; Lymphocytes; Mice; Mice, Knockout; Molecular Chaperones; Mutation, Missense; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Binding; Pyrazines; Wiskott-Aldrich Syndrome; Wiskott-Aldrich Syndrome Protein

2007
Isopeptide and ester bond ubiquitination both regulate degradation of the human dopamine receptor 4.
    The Journal of biological chemistry, 2017, 12-29, Volume: 292, Issue:52

    Topics: Amino Acid Sequence; Arginine; Bortezomib; HEK293 Cells; Humans; Lysine; Neurons; Proteasome Endopeptidase Complex; Protein Binding; Receptors, Dopamine; Receptors, Dopamine D4; Ubiquitin; Ubiquitination

2017
Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma.
    BMC nephrology, 2014, Sep-30, Volume: 15

    Topics: Acute Kidney Injury; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Disease Progression; Edema; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Hypertension, Renal; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Oligopeptides; Podocytes; Proteasome Inhibitors; Proteinuria; Pyrazines; Recurrence; Shock, Septic; Teniposide; Thalidomide; Thrombotic Microangiopathies

2014
Upfront bortezomib, lenalidomide, and dexamethasone compared to bortezomib, cyclophosphamide, and dexamethasone in multiple myeloma.
    European journal of haematology, 2019, Volume: 103, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cyclophosphamide; Dexamethasone; Female; Humans; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Prognosis; Proportional Hazards Models; Survival Analysis; Teniposide; Treatment Outcome

2019